{"url_path":"/sec/sls/8-k/2026-06-25/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1390478/0001104659-26-077556-index.html","accession_number":"0001104659-26-077556","cik":"0001390478","ticker":"SLS","issuer_name":"SELLAS Life Sciences Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1390478/0001104659-26-077556-index.html","primary_entity_key":"0001390478","primary_entity_name":"SELLAS Life Sciences Group, Inc."},"word_count":665,"has_tables":true,"body_markdown":"Item 5.02.\nDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\n** **\n\n**(e) Compensatory Arrangements of Certain Officers**\n\n** **\n\nOn June 24, 2026, SELLAS Life Sciences Group,\nInc. (the “Company”) entered into (i) an amendment (the “Stergiou Amendment”) to that certain employment agreement\neffective as of July 1, 2019 (the “Stergiou Employment Agreement”), by and between the Company and Dr. Angelos Stergiou, the\nCompany’s President and Chief Executive Officer, (ii) an amended and restated severance and change of control letter agreement with\nJohn Burns, the Company’s Senior Vice President and Chief Financial Officer (the “Burns Agreement”), and (iii) an amended\nand restated severance and change of control letter agreement with Dr. Dragan Cicic, the Company’s Senior Vice President and Chief\nDevelopment Officer (the “Cicic Agreement” and collectively with the Stergiou Amendment and the Burns Agreement, the “Agreements”). The Agreements were approved by the Board of Directors (the “Board”) of the Company, upon recommendation of the Compensation\nCommittee of the Board, following a review with the Company’s independent compensation consulting firm of certain market and competitive\npractices relating to executive severance agreements.\n\n \n\n*Amendment to Stergiou Employment Agreement*\n\n \n\nThe Stergiou Amendment amends the Stergiou Employment\nAgreement to provide that certain payments made to Dr. Stergiou as part of his change in control severance benefits will be paid in a\nlump sum payment. The terms of the Stergiou Employment Agreement remain unchanged in all other respects.\n\n \n\n*Amended and Restated Severance and Change of\nControl Letter Agreements with John Burns and Dragan Cicic*\n\n \n\nThe Burns Agreement and the Cicic Agreement each\namend and restate in their entirety the prior change of control severance agreements and non-change of control severance benefits applicable\nto Mr. Burns and Dr. Cicic, respectively.\n\n \n\nUnder the Burns Agreement and the Cicic Agreement,\nif Mr. Burns or Dr. Cicic, as applicable, is terminated by the Company without Cause or resigns for Good Reason, and such termination\ndoes not occur within the Change of Control Period (as defined below), the executive will be entitled to receive the following severance\npayments and benefits: (i) continuing severance pay equal to his then-current base salary for a period of nine months, payable in accordance\nwith the Company’s normal payroll practices; (ii) a pro rata portion of his target bonus for the year of termination, payable in\ninstallments over the nine-month severance period; and (iii) reimbursement of COBRA premiums for continued participation in the Company’s\nmedical and dental benefit plans for up to nine months following termination (or until the executive becomes eligible for coverage under\nanother employer’s group health plan, if earlier).\n\n \n\nUnder the Burns Agreement and the Cicic Agreement,\nif Mr. Burns or Dr. Cicic, as applicable, is terminated by the Company (or its successor) without Cause or resigns for Good Reason within\none month prior to, or one year following, a Change of Control (such period, the “Change of Control Period”), the executive\nwill be entitled to receive the following severance payments and benefits: (i) a lump sum payment equal to 15 months of his then-current\nbase salary; (ii) a lump sum payment equal to his target bonus for the year of termination; (iii) reimbursement of COBRA premiums for\ncontinued participation in the Company’s medical and dental benefit plans for up to 18 months following termination (or until the\nexecutive becomes eligible for coverage under another employer’s group health plan, if earlier); and (iv) immediate vesting in full\nof all then-unvested equity awards held by the executive as of the date of termination.\n\n* *\n\nReceipt of the severance payments and benefits\nis conditioned upon the effectiveness of a separation and general release agreement in a form to be provided by the Company.\n\n \n\nThe foregoing descriptions of the Agreements do\nnot purport to be complete and are qualified by reference to the full text of the Stergiou Amendment, the Burns Agreement and the Cicic\nAgreement, copies of which are attached hereto as Exhibits 10.1, 10.2 and 10.3, respectively, and incorporated herein by reference."}